NDS Corporation acquired additional 11.9% stake in U2Bio CO. LTD. (XKON:A221800) from BSK Potential Fund 1, fund of BSK Investment for KRW 3.8 billion on October 2, 2018. NDS Corporation acquired 0.23 million shares at an offer per share of KRW 17000. BSK Potential Fund 1 does not hold any stake in U2Bio CO. LTD. after completion of the transaction. NDS Corporation completed the acquisition of additional 11.9% stake in U2Bio CO. LTD. (XKON:A221800) from BSK Potential Fund 1, fund of BSK Investment on October 2, 2018.